Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1Completed 1

Sponsor Class

INDUSTRY 7OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 4358Neoplasms 3060Prostatic Neoplasms 1904Colorectal Neoplasms 1739Lung Neoplasms 1557Carcinoma, Non-Small-Cell Lung 1270Pancreatic Neoplasms 981Leukemia, Myeloid, Acute 952Multiple Myeloma 951Lymphoma 912Head and Neck Neoplasms 894Leukemia 852Precursor Cell Lymphoblastic Leukemia-Lymphoma 833Neoplasm Metastasis 794Colonic Neoplasms 786Carcinoma, Hepatocellular 762Ovarian Neoplasms 758Melanoma 752Stomach Neoplasms 743Rectal Neoplasms 701Brain Neoplasms 699Lymphoma, Non-Hodgkin 663Leukemia, Lymphocytic, Chronic, B-Cell 618Uterine Cervical Neoplasms 608Lymphoma, Follicular 559Glioblastoma 542Recurrence 541Hodgkin Disease 532Esophageal Neoplasms 527Myelodysplastic Syndromes 508

Interventions

nilotinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × OTHER × Giant Cell Tumor of Tendon Sheath × Clear all
NCT01207492 2026-02-20

Nilotinib in Patients With Relapsed or Metastatic Pigmented Villonodular Synovitis/Tenosynovial Giant Cell Tumor/Diffuse-Type Giant Cell Tumor

Dana-Farber Cancer Institute

Phase 2 Completed
17 enrolled 8 charts

Giant Cell Tumor of Tendon Sheath, Synovitis, Pigmented Villonodular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡